United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 1998 NY Rulings > NY C80804 - NY C80861 > NY C80856

Previous Ruling Next Ruling
NY C80856

October 29, 1997

CLA-2-30:RR:NC:2:238 C80856


TARIFF NO.: 3004.90.9040

Mr. Desmond Flynn
SmithKline Beecham Pharmaceuticals
200 N. 16th Street
Philadelphia, PA 19102

RE: The tariff classification of Requip (Ropinirole hydrochloride) tablets from the United Kingdom

Dear Mr. Flynn:

In your letter dated October 16, 1997, you requested a tariff classification ruling.

The subject product, Requip , consists of tablets containing the anti-Parkinsonian drug, Ropinirole hydrochloride (CAS-91374-2-8), as the active ingredient.

The applicable subheading for Requip tablets will be 3004.90.9040, Harmonized Tariff Schedule of the United States (HTS), which provides for: "Medicaments ... consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Other." The rate of duty will be free.

This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number (301) 443-6553.

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Cornelius Reilly at 212-466-5770.


Robert B. Swierupski

Previous Ruling Next Ruling

See also: